Hepatitis E virus infection

Lancet

Volumn 355, Issue 9203, 2000, Pages 578-

  Purcell, R H ^a   Emerson, S U ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS E VACCINE; HEPATITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY TITER; ASIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEPATITIS E; HUMAN; IMMUNOPROPHYLAXIS; LETTER; NONHUMAN; PRIORITY JOURNAL; RURAL AREA; SEROPREVALENCE; VIRUS TRANSMISSION;

EID: 0034639692     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)73231-1     Document Type: Letter

References (5)

1. SJ Skidmore Factors in spread of hepatitis E Lancet 354 1999 1049 1050
2. EE Mast MJ Alter PV Holland Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group Hepatology 27 1998 857 861
3. Y Kabrane-Lazizi JB Fine J Elm Evidence for widespread infection of wild rats with hepatitis E virus in the United States Am J Trop Med Hyg 61 1999 331 335
4. SA Tsarev TS Tsareva SU Emerson Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge Vaccine 15 1997 1834 1838
5. BF Scharschmidt Hepatitis E: a virus in waiting Lancet 346 1995 519 520